Maria Primo
About Maria Primo
Maria Primo is a Molecular Biology Scientist with extensive experience in gene regulatory processes and viral infections. She has worked at notable institutions including Aarhus University, University of Cambridge, and Wellcome Sanger Institute.
Work at Alloy Therapeutics
Maria Primo currently serves as a Molecular Biology Scientist at Alloy Therapeutics, Inc. since 2020. In this role, she applies her expertise in molecular biology to contribute to the company's research initiatives. Her work focuses on advancing the understanding of gene regulatory processes and their implications in various biological contexts.
Education and Expertise
Maria Primo holds a Doctor of Philosophy (PhD) in Molecular Medicine from Aarhus University, where she studied from 2012 to 2017. She also earned a Master’s Degree in Molecular Biology and Genetics from Faculdade de Ciências da Universidade de Lisboa, completing her studies from 2009 to 2011. Additionally, she obtained a Bachelor’s Degree from the same institution from 2006 to 2009. Her educational background equips her with a strong foundation in molecular biology and genetics.
Background
Maria Primo began her academic journey at Faculdade de Ciências da Universidade de Lisboa, where she completed her Bachelor's and Master's degrees. She then pursued a PhD at Aarhus University, focusing on gene regulation and immune responses. Following her doctoral studies, she worked at the Wellcome Sanger Institute and Open Targets in Cambridge, UK, gaining valuable experience in research and data analysis.
Research Focus
In her postdoctoral phase, Maria aims to deepen her understanding of gene regulatory processes and downstream signaling pathways that regulate viral infections in human macrophages. She explores single-cell RNA sequencing techniques to monitor cellular heterogeneity and population dynamics during macrophage stimulation. Her research also includes characterizing miRNA responses during the innate immune response to viral infections.
Previous Positions
Before her current role at Alloy Therapeutics, Maria held several positions in prominent research institutions. She was a Visiting Scientist at the Wellcome Sanger Institute from 2017 to 2020 and worked as a Postdoctoral Fellow at Open Targets from 2017 to 2019. These roles allowed her to develop computational skills for analyzing high-throughput sequencing data, enhancing her research capabilities.